10 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Infections in HIV-AIDS Bacterial ... • CD4 > 200: M.tuberculosis ... • CD4 < 200: M.tuberculosis ... and sputum cx (Bacterial ... Pulmonary #Infections #HIVAIDS
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Typhoid fever - Bacterial ... meningitis - Tuberculous ... meningitis - Tuberculous ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Preventing and Treating Bacterial ... HIV-AIDS Preventing Bacterial ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... intracellular rod-shaped bacteria ... Response: • Most bacteria ... staining, NAA (PCR ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... intracellular rod-shaped bacteria ... Response: • Most bacteria ... staining, NAA (PCR ... TB #Diagnosis #Management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Effusion Lymphoma (PEL ... KS treatment PEL ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
Pneumocystis Pneumonia (PCP ... Prevention #Treatment #PCP ... opportunistic #infections #HIVAIDS ... #management #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... Mycobacterium #Tuberculosis ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology